Manager × security

Avoro Capital Advisors LLC UTHR holdings history

Who else holds this security? →

UNITED THERAPEUTICS CORP · CUSIP 91307C102 · CIK 1633313

This is the oldest quarter open without an account, so changes against the quarter before it are withheld. Sign in to see them.
Citable facts

As of 2026-06-30, Avoro Capital Advisors LLC reported 2.78M UTHR (shares), valued at $1.51B, or 13.52% of its reported non-derivative portfolio. Filed 2026-08-14.

Verify history & sources →
Portfolio weight and quantity history
Reported portfolio weight
13.52%
Shares
2.78M
2,777,777
Reported value
$1.51B
USD

Shares increased 5.62%; reported value decreased 3.49%, and weight changed -1.84 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.

Left: % · Right: Shares · Independently scaled axes

Exact data and methodology

Axes scale independently; a crossing does not mean equal values. Weight uses each quarter's total reported non-derivative value. Same CUSIP; missing quarters are gaps, not zero. Revised history may include later disclosures.

QuarterWeightQuantitySource
Q2 202613.52%2,777,777SEC filing ↗Filed Aug 14, 2026
Q1 202615.36%2,630,000SEC filing ↗Filed May 15, 2026
Q4 202512.48%2,606,060SEC filing ↗Filed Mar 16, 2026Amended
Q3 202510.97%2,022,222SEC filing ↗Filed Nov 14, 2025
Q2 202511.93%2,370,000SEC filing ↗Filed Aug 14, 2025
Q1 202512.87%2,675,000SEC filing ↗Filed May 15, 2025
Q4 202413.78%2,760,300SEC filing ↗Filed Feb 14, 2025
Q3 202414.94%2,858,888SEC filing ↗Filed Nov 14, 2024
Q2 202412.13%2,858,888SEC filing ↗Filed Aug 14, 2024
Q1 20247.66%2,858,888SEC filing ↗Filed May 15, 2024
Q4 20238.68%2,858,888SEC filing ↗Filed Feb 14, 2024

History & evidence by quarter

QuarterWeightQuantityValueChange explainedSource
Q4 20238.68%2,858,888$628.64MThe prior quarter is outside the free window. Sign in for the comparison.SEC filing ↗
Filed Feb 14, 2024
Q1 20247.66%2,858,888$656.74MShares unchanged; reported value increased 4.47%, and weight changed -1.02 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 15, 2024
Q2 202412.13%2,858,888$910.70MShares unchanged; reported value increased 38.67%, and weight changed +4.47 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 14, 2024
Q3 202414.94%2,858,888$1.02BShares unchanged; reported value increased 12.49%, and weight changed +2.81 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Nov 14, 2024
Q4 202413.78%2,760,300$973.94MShares decreased 3.45%; reported value decreased 4.93%, and weight changed -1.16 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Feb 14, 2025
Q1 202512.87%2,675,000$824.62MShares decreased 3.09%; reported value decreased 15.33%, and weight changed -0.91 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 15, 2025
Q2 202511.93%2,370,000$681.02MShares decreased 11.40%; reported value decreased 17.41%, and weight changed -0.94 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 14, 2025
Q3 202510.97%2,022,222$847.74MShares decreased 14.67%; reported value increased 24.48%, and weight changed -0.96 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Nov 14, 2025
Q4 202512.48%2,606,060$1.27BShares increased 28.87%; reported value increased 49.79%, and weight changed +1.51 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Mar 16, 2026
Q1 202615.36%2,630,000$1.56BShares increased 0.92%; reported value increased 22.82%, and weight changed +2.88 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 15, 2026
Q2 202613.52%2,777,777$1.51BShares increased 5.62%; reported value decreased 3.49%, and weight changed -1.84 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 14, 2026
Avoro Capital Advisors LLC · UNITED THERAPEUTICS CORP

Take these holdings further.

This page includes 11 of 11 reported holdings. Sign in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and get the complete set through the Akkru API.

  • Download CSV
  • Earlier quarters
  • Advanced screening & filtering
  • API & AI access
Already have an account?

+ New accounts get free API credits to explore data beyond ownership filings.

For AI agents & developers

The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account.

Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.

MCP  https://api.akkrudata.ai/mcp

get_institutional_portfolio
{"cik":"1633313","quarter":"2026Q2","cusip":"91307C102"}

get_institutional_manager_history
{"cik":"1633313","page_size":100}

Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.

MCP endpoint
https://api.akkrudata.ai/mcp
API / MCP documentation
/documents
llms.txt
/llms.txt
Sources, coverage & how to read this data

Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.

13F reports quarter-end long positions in securities traded on US exchanges, filed by managers holding at least $100 million of such securities; it is not the manager's full portfolio, not assets under management, and value changes are not returns. Weights use the reported total value as denominator. Option rows show notional value, not premium or net exposure. Amendments are merged into the quarter when Akkru could match them.